BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 9354461)

  • 1. B lymphocytes from patients with chronic lymphoproliferative disorders are equipped with different costimulatory molecules.
    Trentin L; Zambello R; Sancetta R; Facco M; Cerutti A; Perin A; Siviero M; Basso U; Bortolin M; Adami F; Agostini C; Semenzato G
    Cancer Res; 1997 Nov; 57(21):4940-7. PubMed ID: 9354461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B7 costimulatory molecules from malignant cells in patients with b-cell chronic lymphoproliferative disorders trigger t-cell proliferation.
    Trentin L; Perin A; Siviero M; Piazza F; Facco M; Gurrieri C; Galvan S; Adami F; Agostini C; Pizzolo G; Zambello R; Semenzato G
    Cancer; 2000 Sep; 89(6):1259-68. PubMed ID: 11002221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of adhesion molecules in chronic B-cell lymphoproliferative disorders.
    Lúcio PJ; Faria MT; Pinto AM; da Silva MR; Correia Júnior ME; da Costa RJ; Parreira AB
    Haematologica; 1998 Feb; 83(2):104-11. PubMed ID: 9549920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M; Sukova V; Coupek P; Brychtova Y; Mayer J
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression patterns of costimulatory molecules on cells derived from human hematological malignancies.
    Zheng Z; Takahashi M; Aoki S; Toba K; Liu A; Osman Y; Takahashi H; Tsukada N; Suzuki N; Nikkuni K; Furukawa T; Koike T; Aizawa Y
    J Exp Clin Cancer Res; 1998 Sep; 17(3):251-8. PubMed ID: 9894758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of tumour necrosis factor (TNF) receptor/ligand superfamily co-stimulatory molecules CD40, CD30L, CD27L, and OX40L in murine hearts with chronic ongoing myocarditis caused by coxsackie virus B3.
    Seko Y; Takahashi N; Oshima H; Shimozato O; Akiba H; Kobata T; Yagita H; Okumura K; Azuma M; Yazaki Y
    J Pathol; 1999 Aug; 188(4):423-30. PubMed ID: 10440754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct or reverse correlations within the expression of activation, differentiation or T-B cooperation molecules on chronic lymphocytic leukemia B cells.
    Sellitto A; De Fanis U; Romano C; Dalla Mora L; Guastafierro S; Tirelli A; Lucivero G
    Minerva Med; 2003 Oct; 94(5):331-6, 336-9. PubMed ID: 14973427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD40 triggering enhances fludarabine-induced apoptosis of chronic lymphocytic leukemia B-cells through autocrine release of tumor necrosis factor-alpha and interferon-gama and tumor necrosis factor receptor-I-II upregulation.
    de Totero D; Tazzari PL; Capaia M; Montera MP; Clavio M; Balleari E; Foa R; Gobbi M
    Haematologica; 2003 Feb; 88(2):148-58. PubMed ID: 12604404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vdelta1 T lymphocytes from B-CLL patients recognize ULBP3 expressed on leukemic B cells and up-regulated by trans-retinoic acid.
    Poggi A; Venturino C; Catellani S; Clavio M; Miglino M; Gobbi M; Steinle A; Ghia P; Stella S; Caligaris-Cappio F; Zocchi MR
    Cancer Res; 2004 Dec; 64(24):9172-9. PubMed ID: 15604289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD5+ chronic B-cell leukemia with features intermediate to chronic lymphocytic leukemia and hairy cell leukemia.
    Aljurf M; Cornbleet PJ; Michel F
    Hematol Pathol; 1994; 8(3):99-109. PubMed ID: 7527021
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metalloprotease inhibitors block release of soluble CD27 and enhance the immune stimulatory activity of chronic lymphocytic leukemia cells.
    Kato K; Chu P; Takahashi S; Hamada H; Kipps TJ
    Exp Hematol; 2007 Mar; 35(3):434-42. PubMed ID: 17309824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The CD5/CD72 receptor system is coexpressed with several functionally relevant counterstructures on human B cells and delivers a critical signaling activity.
    Cerutti A; Trentin L; Zambello R; Sancetta R; Milani A; Tassinari C; Adami F; Agostini C; Semenzato G
    J Immunol; 1996 Sep; 157(5):1854-62. PubMed ID: 8757302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional and clinical relevance of CD44 variant isoform expression on B-cell chronic lymphocytic leukemia cells.
    Zarcone D; De Rossi G; Tenca C; Marroni P; Mauro FR; Cerruti GM; Albi N; Fiorucci S; Velardi A; Grossi CE
    Haematologica; 1998 Dec; 83(12):1088-98. PubMed ID: 9949626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of CD79b, CD5 and CD19 in mature B-cell lymphoproliferative disorders.
    Cabezudo E; Carrara P; Morilla R; Matutes E
    Haematologica; 1999 May; 84(5):413-8. PubMed ID: 10329919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro.
    Tretter T; Schuler M; Schneller F; Brass U; Esswein M; Aman MJ; Huber C; Peschel C
    Cell Immunol; 1998 Oct; 189(1):41-50. PubMed ID: 9758693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD27 in B-cell chronic lymphocytic leukemia. Cellular expression, serum release and correlation with other soluble molecules belonging to nerve growth factor receptors (NGFr) superfamily.
    Molica S; Vitelli G; Levato D; Crispino G; Dell'Olio M; Dattilo A; Matera R; Gandolfo GM; Musto P
    Haematologica; 1998 May; 83(5):398-402. PubMed ID: 9658722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of CD27-CD70 on early B cell progenitors in the bone marrow: implication for diagnosis and therapy of childhood ALL.
    Nilsson A; de Milito A; Mowafi F; Winberg G; Björk O; Wolpert EZ; Chiodi F
    Exp Hematol; 2005 Dec; 33(12):1500-7. PubMed ID: 16338493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of CD40/CD40 ligand and Bcl-2 family proteins in labial salivary glands of patients with Sjögren's syndrome.
    Nakamura H; Kawakami A; Tominaga M; Migita K; Kawabe Y; Nakamura T; Eguchi K
    Lab Invest; 1999 Mar; 79(3):261-9. PubMed ID: 10092062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cells.
    Couderc B; Zitvogel L; Douin-Echinard V; Djennane L; Tahara H; Favre G; Lotze MT; Robbins PD
    Cancer Gene Ther; 1998; 5(3):163-75. PubMed ID: 9622100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of human B cell function by recombinant CD40 ligand and other TNF-related ligands.
    Jumper MD; Nishioka Y; Davis LS; Lipsky PE; Meek K
    J Immunol; 1995 Sep; 155(5):2369-78. PubMed ID: 7650371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.